Forte Biosciences (FBRX) Earnings Date & Reports

A.I. Advisor

published Earnings

FBRX is expected to report earnings to fall 23.15% to -20 cents per share on November 11

Forte Biosciences FBRX Stock Earnings Reports

Q3'24

Est.

$-0.21

Q2'24

Missed

by $0.11

Q1'24

Est.

$-0.16

Q4'23

Beat

by $0.28

Q3'23

Beat

by $0.31

The last earnings report on August 14 showed earnings per share of -27 cents, missing the estimate of -15 cents. With 6.17K shares outstanding, the current market capitalization sits at 11.13M.

View a ticker or compare two or three

Compare

FBRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For FBRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3060 Pegasus Park Drive

Phone

+1 310 618-6994

Employees

Web

https://www.fortebiorx.com